Frazier Financial Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-250
Closed -$1.65K 844
2024
Q3
$1.65K Hold
250
﹤0.01% 721
2024
Q2
$1.88K Hold
250
﹤0.01% 802
2024
Q1
$2.49K Buy
+250
New +$2.49K ﹤0.01% 731